HighTower Advisors
RNXT icon

HighTower Advisors’s RenovoRx RNXT Stock Holding History

HighTower Advisors’s Portfolio RNXT Stock Details RNXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.6K Hold
20,000
– – ﹤0.01% 3770
2026
Q1 		$20.2K Hold
20,000
– – ﹤0.01% 3759
2025
Q4 		$16.8K Sell
20,000
-20,000
-50% -$20K ﹤0.01% 3618
2025
Q3 		$50.8K Hold
40,000
– – ﹤0.01% 3607
2025
Q2 		$52.6K Hold
40,000
– – ﹤0.01% 3543
2025
Q1 		$39.6K Buy
+40,000
New +$46.6K ﹤0.01% 3473

Other funds holding RNXT

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

HighTower Advisors's RNXT Position: Q2 2026 in Review

HighTower Advisors held its RenovoRx (RNXT) position steady in Q2 2026 at 20,000 shares worth $19.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3770.

HighTower Advisors first reported a position in RNXT in Q1 2025 and has held it in 6 quarters since. The position peaked at $52.6K in Q2 2025. 28 funds tracked by Wall St. Rank hold RNXT as of Q2 2026.

  • HighTower Advisors held 20,000 shares of RenovoRx worth $19.6K as of Q2 2026.
  • HighTower Advisors left its RenovoRx share count unchanged in Q2 2026.
  • RenovoRx made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #3770 holding.
  • HighTower Advisors first reported a position in RenovoRx in Q1 2025 and has held it in 6 quarters since.
  • HighTower Advisors's RenovoRx position peaked at $52.6K in Q2 2025.
  • 28 funds tracked by Wall St. Rank held RenovoRx as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.